CSX — CSX Corporation

Sentiment turned bullish after Q2 2026 earnings beat: revenue rose 10% YoY to a record $3.94B, EPS rose 23% to $0.54, and operating margin expanded 240bps to 38.3%. Multiple sell-side firms raised targets — Barclays to $60, BofA to $56, JPMorgan to $58 — and the consensus rating is Buy. As of 2026-08-27, the stock sits just below its 52-week high with positive momentum, though the market is already pricing in a lot of good news.

The 3-year trend shows a clear inflection, not just a one-off blip. Revenue faded from the $3.6–3.7B range through 2024 to a low of $3.42B in Q1 2025, then rebounded to a record $3.94B in Q2 2026. The sequential Q1-to-Q2 2026 revenue jump was 13%, versus about 4.4% in 2025 and 0.5% in 2024, signaling an acceleration. Operating income in Q2 2026 was $1.51B, up 17% YoY, and diluted EPS of $0.54 was up 23% YoY. TTM operating margin is 34.2% and net margin is 22.2%; with volumes up 6% and Q3 estimates being revised higher, the momentum appears real, though durability still depends on freight demand holding up.

Expensive. As of 2026-08-27, CSX trades at 29.8x TTM EPS of $1.737 and roughly 25.7x the forward EPS estimate of $2.008. Its 5-year average P/E is 19.8x, and its 5-year average P/S is 5.01x versus 6.58x today. P/B is 6.79x and TTM PEG is 4.86x. Even after crediting CSX's margin quality and earnings growth, the stock is priced well above its own historical multiple and leaves little room for error.

The price is not discounting a turnaround; it is discounting continued execution. At $51.54, the market is paying 29.8x trailing earnings and 25.7x forward estimates, so the bull case requires CSX to keep beating and raising. If Q3 2026 delivers the expected ~23% EPS growth, the current price can be defended; if volume or pricing disappoints, multiple compression toward the low- to mid-40s is a real risk. This is an earnings-delivery stock, not a cheap-value stock.

As of 2026-08-27, RSI was 59.87 — positive but not overbought. Price was 1.65% above its 20-day SMA, 3.64% above its 50-day SMA, and 20.65% above its 200-day SMA, with the 52-week high at $53.60 just overhead. The trend is clearly bullish, but being 20% above the 200-day SMA means a pullback is normal risk. Chasing here is less attractive; a dip toward the 20-day near $50.70 or the 50-day near $49.70 would offer a better entry zone.

• Resilient intermodal and merchandise demand supporting rail volumes and pricing power.
• US industrial/coal/freight cycle determines near-term volume swings; a hard landing would hit CSX hard.
• Interest rates and inflation affect valuation multiples, fuel costs, and labor costs.
• Regulatory scrutiny of Class I rail service, labor dynamics, and Surface Transportation Board merger/competition issues.
• Supply chain normalization and infrastructure projects like Howard Street Tunnel add long-term capacity tailwinds.

• Q3 2026 earnings expected in October — consensus implies strong YoY growth; a beat/raise would extend momentum.
• Continued volume growth across merchandise, intermodal, and coal, plus further operating margin expansion.
• Capital allocation updates: dividends and buybacks, with management targeting around 50% free cash flow growth.
• Analyst estimate revisions have been moving higher; further upgrades could support the stock.

• Cyclical freight downturn would hit volumes and operating leverage hard.
• Valuation risk: 29.8x TTM P/E versus a 19.8x 5-year average leaves significant downside if growth stalls.
• Balance sheet is leveraged: debt/equity of 1.375 and current ratio of 0.82; long-term debt is $17.2B.
• Free cash flow has been lumpy — 2025 Q2 and Q3 were negative due to high capex and weaker operating cash flow.
• Regulatory, labor, and competitive pressures could keep a lid on pricing or create cost overruns.

CSX is a high-quality railroad with strong margins, pricing discipline, and a genuine operating inflection in 2026. The problem is price: as of 2026-08-27, the stock already reflects a lot of that quality, trading at a noticeable premium to its own history. I lean cautiously bullish — this is a good business worth owning on pullbacks, but not an obvious high-upside entry at $51.54.

Applied a 25.0x forward P/E multiple to the consensus forward EPS estimate of $2.008, which is a premium to CSX's 5-year average P/E of 19.8x to reflect improved margins, ROE, and growth momentum, but a slight discount to the current 25.7x forward multiple because the stock looks rich versus history.